Credit Suisse Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $90

Credit Suisse analyst Kaumil Gajrawala maintains Colgate-Palmolive (NYSE:CL) with a Outperform and lowers the price target from $95 to $90.

byBenzinga Newsdesk

January 31, 2022

1 minute read

Credit Suisse analyst Kaumil Gajrawala maintains Colgate-Palmolive (NYSE:CL) with a Outperform and lowers the price target from $95 to $90.

Cosmetics Maker Revlon Files For Bankruptcy

By Shivani Kumaresan

Today, 4:19 AM

Cosmetics brand Revlon Inc (NYSE:REV) has filed for bankruptcy under Chapter 11 after facing heavy debt. It has filed voluntary petitions for…

REV

US Stocks On Track For Lackluster Start On Data-Heavy Thursday — Retail Earnings, Cisco, Nvidia, Alibaba In Focus

By Shanthi Rexaline

Today, 4:19 AM

The index futures point to a nervous start by Wall Street stocks on Thursday, as the inflation-induced euphoria fades and traders turn their focus back to the Fed and the rate outlook.

AMAT

News

Vivavi Announced AVX-10K Flight Line Test Set Approved For Use On Boeing Commercial Aircraft

By Charles Gross

Today, 4:19 AM

Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced the AVX-10K Flight Line Test Set has been approved for use on all Boeing commercial aircraft where the IFR4000 and IFR6000 had previously been approved.

Lemonade Q2 EPS $(0.90) Misses $(0.89) Estimate, Sales $28.20M Beat $26.80M Estimate

By Benzinga Newsdesk

Today, 4:19 AM

Lemonade (NYSE:LMND) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.89) by 1.12 percent. This is a 49.15 percent increase over losses of $(1.77) per share from the same

LMND

Credit Suisse Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $90

Related Posts

Cosmetics Maker Revlon Files For Bankruptcy

US Stocks On Track For Lackluster Start On Data-Heavy Thursday — Retail Earnings, Cisco, Nvidia, Alibaba In Focus

Vivavi Announced AVX-10K Flight Line Test Set Approved For Use On Boeing Commercial Aircraft

Lemonade Q2 EPS $(0.90) Misses $(0.89) Estimate, Sales $28.20M Beat $26.80M Estimate